John P. Longenecker Ph.D., Director at Pacira Pharmaceuticals, Inc. (PCRX), bought 300 shares at $66.55 ($20K) on 2016-01-12, disclosed to the SEC on 2016-01-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCRX | SELL | 2019-12-04 | $60K | — | Filing → |
| ALRN | BUY | 2018-08-14 | $25K | — | Filing → |
| PCRX | SELL | 2015-03-16 | $286K | — | Filing → |